Nanotech Stock Directory
Publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock Exchanges. Directory includes nanotech - biotech companies, nanotech water and renewable energy companies and more.
Investorideas.com is compensated by featured companies: read disclaimers and disclosures
3M Co. (NYSE:MMM) 3M scientists and researchers are exploring a new world at the nanometer level, where materials exhibit unique physical, chemical and biological properties. These unusual properties are already being exploited in our hard coatings, dental restoratives and brightness-enhancing optical films (used in LCD displays). Many 3M technology platforms, including adhesives and pharmaceuticals, are being influenced by the emergence of nano-sized particles.
A123 Systems, Inc. (NasdaqGM:AONE) develops and manufactures advanced lithium-ion batteries and battery systems for the transportation, electric grid services and consumer markets. Founded in 2001 and headquartered in Massachusetts, A123 Systems' proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.
ABB Ltd. (NYSE:ABB) is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB group of companies operates in some 100 countries and employs approximately 120,000 people. Nanotech R&D: Nano-designed dielectrics can be engineered to an exact specification with an improved response to changing electric fields. This opens up the possibilities for cables, bushings, surge arresters and insulating materials. At the same time ABB is perfecting a nano-structured sliding bearing that works in MV and HV switchgear without oil, offering lower operating costs and less environmental impact.
Accelrys (NasdaqGM:ACCL) is a Scientific Informatics software and services company for life sciences, chemical and materials R&D. We enable our customers to both accelerate their research process to more rapidly discover new therapeutics, materials and compounds; and to introduce new efficiencies into the process that drive lower costs The MesoProp is a new research tool which is used to predict the bulk properties of multicomponent nanostructured materials systems. The research applications for MesoProp include studies of polymers, surfactants and continuous phases which are fundamental to the development of surface coatings, adhesives, sealants, elastomers, cements, composite materials, gels, and laminates.
Acusphere Inc. (OTCPK:ACUS) is a specialty pharmaceutical company, primarily focused on the development of Imagify, a cardiovascular drug for the detection of coronary artery disease. Acusphere is in the process of seeking regulatory approval of Imagify in Europe, and negotiating a Special Protocol Assessment with FDA for an additional trial required for US approval. Imagify was created using Acusphere's proprietary porous microparticle technology , which was also used to create three other drugs which have begun clinical development - AI-525 for acute pain, AI-850 for oncology and AI-128 for asthma. AI-525 and AI-850 were sold to Cephalon in transactions totaling $31 million. AI-128 was developed in collaboration with Elan, who contributed $7.5 million to the program. Acusphere's technology has the potential to create a wide variety of new drugs by reformulating hydrophobic drugs and creating sustained release formulations of existing drugs.
View the full nanotech stock directory at Investorideas.com - login as a member or access in PDF